Freya Biosciences

About Freya Biosciences

Freya Biosciences is a clinical-stage company focused on empowering women through innovative biomedical solutions for improved reproductive health. They aim to revolutionize women's health with microbial immunotherapies that address chronic inflammation underlying various reproductive system diseases.

Products & Services

Microbial Immunotherapies:Target immune drivers underlying reproductive system conditions such as IVF failure, endometriosis infertility, preterm birth, and other women's health issues.

FB101:A therapeutic solution to treat women with asymptomatic vaginal dysbiosis, with positive topline clinical trial results announced.

Specialties

Microbial Immunotherapies Reproductive Health IVF and Natural Conception Solutions Endometriosis Infertility Treatments Preterm Birth Interventions Data-Driven Women's Health Research

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 10400000 MR: - FA: $10.4 million FAN: 10400000	D: 2024-11-19 FD: 2024-11-19	2 investors
2	RT: Series A T: - FT: Series A	A: 38000000 MR: - FA: $38 million FAN: 38000000	D: 2023-12-12 FD: 2023-12-12	8 investors

Series A Latest

2024-11-19

$10.4M

2 investors (Pro only)

Series A 2023-12-12

$38.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Colleen Acosta

CEO, Co-Founder

J

Johan van Hylckama Vlieg

CSO, Co-Founder

P

Per Cantor

CMO

C

Crilles Larsen

CTO

P

Peter Bisgaard

Chairman

U

Ulrich Binné

CBO, Co-Founder

View 22 more team members with Pro

Unlock Full Team Directory

Recent News